Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 1
1956 2
1958 3
1959 3
1960 6
1962 8
1963 10
1964 5
1965 8
1966 4
1967 4
1968 4
1969 6
1970 1
1971 9
1972 5
1973 5
1974 8
1975 7
1976 16
1977 6
1978 12
1979 9
1980 10
1981 16
1982 11
1983 5
1984 20
1985 19
1986 20
1987 26
1988 24
1989 14
1990 17
1991 23
1992 34
1993 43
1994 47
1995 42
1996 57
1997 59
1998 76
1999 97
2000 85
2001 86
2002 100
2003 128
2004 128
2005 163
2006 208
2007 271
2008 307
2009 354
2010 388
2011 489
2012 590
2013 744
2014 895
2015 1001
2016 1008
2017 1010
2018 1192
2019 1379
2020 1705
2021 1997
2022 2347
2023 2285
2024 983

Text availability

Article attribute

Article type

Publication date

Search Results

18,360 results

Results by year

Filters applied: . Clear all
Page 1
Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): a randomised, open-label, international phase 3 study.
Qin S, Chan SL, Gu S, Bai Y, Ren Z, Lin X, Chen Z, Jia W, Jin Y, Guo Y, Hu X, Meng Z, Liang J, Cheng Y, Xiong J, Ren H, Yang F, Li W, Chen Y, Zeng Y, Sultanbaev A, Pazgan-Simon M, Pisetska M, Melisi D, Ponomarenko D, Osypchuk Y, Sinielnikov I, Yang TS, Liang X, Chen C, Wang L, Cheng AL, Kaseb A, Vogel A; CARES-310 Study Group. Qin S, et al. Among authors: yang ts. Lancet. 2023 Sep 30;402(10408):1133-1146. doi: 10.1016/S0140-6736(23)00961-3. Epub 2023 Jul 24. Lancet. 2023. PMID: 37499670 Clinical Trial.
Efficacy and safety of once weekly semaglutide 2·4 mg for weight management in a predominantly east Asian population with overweight or obesity (STEP 7): a double-blind, multicentre, randomised controlled trial.
Mu Y, Bao X, Eliaschewitz FG, Hansen MR, Kim BT, Koroleva A, Ma RCW, Yang T, Zu N, Liu M; STEP 7 Study Group. Mu Y, et al. Among authors: yang t. Lancet Diabetes Endocrinol. 2024 Mar;12(3):184-195. doi: 10.1016/S2213-8587(23)00388-1. Epub 2024 Feb 5. Lancet Diabetes Endocrinol. 2024. PMID: 38330988 Clinical Trial.
Harnessing artificial intelligence for prostate cancer management.
Zhu L, Pan J, Mou W, Deng L, Zhu Y, Wang Y, Pareek G, Hyams E, Carneiro BA, Hadfield MJ, El-Deiry WS, Yang T, Tan T, Tong T, Ta N, Zhu Y, Gao Y, Lai Y, Cheng L, Chen R, Xue W. Zhu L, et al. Among authors: yang t. Cell Rep Med. 2024 Apr 16;5(4):101506. doi: 10.1016/j.xcrm.2024.101506. Epub 2024 Apr 8. Cell Rep Med. 2024. PMID: 38593808 Free PMC article. Review.
Photosensitizer-loaded hydrogels: A new antibacterial dressing.
Liu S, Feng Y, Tan Y, Chen J, Yang T, Wang X, Li L, Wang F, Liang H, Zhong JL, Qi C, Lei X. Liu S, et al. Among authors: yang t. Wound Repair Regen. 2024 Feb 3. doi: 10.1111/wrr.13156. Online ahead of print. Wound Repair Regen. 2024. PMID: 38308577 Review.
Proton radiobiology and uncertainties.
Yang TC. Yang TC. Radiat Meas. 1999 Jun;30(3):383-92. doi: 10.1016/s1350-4487(99)00209-7. Radiat Meas. 1999. PMID: 11543142 Review.
18,360 results
You have reached the last available page of results. Please see the User Guide for more information.